1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal (2013)

Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal (2013)

  1. Calliope
    Annals of Internal Medicine. 2013;158:1-9.

    Coffin PO, Sullivan SD.

    Abstract
    Opioid overdose, a major source of morbidity and mortality worldwide, accounts for half of the mortality among heroin users and is a leading cause of death among adults in the United States. Naloxone is a safe, effective, short-acting opioid antagonist for intravenous, intramuscular, subcutaneous, or intranasal administration by medical personnel and—since the late 1990s—laypersons to reverse opioid overdose. Naloxone distribution is endorsed by the American Medical Association, generally integrated into preexisting services, and targeted at anyone at risk for witnessing or having an opioid overdose. Naloxone “kits” are usually wallet-sized packets containing 2 doses of naloxone and other items, including syringes, brochures, simple rescue breathing masks, and brief educational materials about overdose risks and management. As of 2010, a total of 188 U.S. programs distributing naloxone reported training 53 032 persons and recording 10 171 reversals